UNI-BIO SCIENCE GROUP LTD

Uni‑Bio Science Group’s 1H 2026 report shows HK$273.8 m revenue and strong cash flow amid strategic biopharma expansion and portfolio optimisation.

Uni-Bio Science Group Ltd has received marketing approval from China’s NMPA for its new ophthalmology product, Diquafosol Sodium Eye Drops, which targets dry eye syndrome affecting an estimated 360 million individuals in China.